论文信息 - First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse - 字舞流文

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

A. Roberts | B. Smith | S. Busfield | J. Altman | R. Walter | G. Roboz | M. DeWitte | D. Bensen-Kennedy | Sourav Ghosh | S. Dasen | Anna K. Ferguson | M. Barnden | K. F. Orlowski | L. Garrett | T. Curcio | A. Dyson | B. Sedgmen | Roslyn Davis | Sarah Hosback | Anna Ferguson